Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43 (market cap $7.04B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 4.8× uniQure N.V. Ordinary Shares's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| IONS | QURE | |
|---|---|---|
Market Cap | $7.04B | $1.48B |
Volume | 2,977,440 | 2,488,780 |
Sector | Health | Health |
52-Week High | $86.50 | $70.59 |
52-Week Low | $42.38 | $9.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $728.62M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
